JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 180 filers reported holding JUNO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.57 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,495,000 | +34.7% | 50,000 | 0.0% | 0.01% | +44.4% |
| Q1 2017 | $1,110,000 | -26.4% | 50,000 | -37.5% | 0.01% | -40.0% |
| Q4 2016 | $1,508,000 | -37.2% | 80,000 | 0.0% | 0.02% | -31.8% |
| Q3 2016 | $2,401,000 | -21.9% | 80,000 | 0.0% | 0.02% | -31.2% |
| Q2 2016 | $3,075,000 | +0.9% | 80,000 | 0.0% | 0.03% | 0.0% |
| Q1 2016 | $3,047,000 | -13.4% | 80,000 | 0.0% | 0.03% | +10.3% |
| Q4 2015 | $3,518,000 | +8.1% | 80,000 | 0.0% | 0.03% | -3.3% |
| Q3 2015 | $3,255,000 | -23.7% | 80,000 | 0.0% | 0.03% | -18.9% |
| Q2 2015 | $4,266,000 | -29.7% | 80,000 | -20.0% | 0.04% | -26.0% |
| Q1 2015 | $6,066,000 | +16.2% | 100,000 | 0.0% | 0.05% | -5.7% |
| Q4 2014 | $5,222,000 | – | 100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |